Facebook Linkedin Pinterest Reddit Twitter
NON PROFIT
1 min.Read

American College of Cardiovascular Virtual Summit – Feb 17-19, 2022

Conference features three days of plenary sessions, mini-intensives, workshops and access to on-demand content

American College of Cardiology’s Cardiovascular Summit Virtual (CV Summit) will feature three days of live content on Feb. 17-19, 2022, providing opportunities for the entire CV team to learn from multi-dimensional education courses on CV management and leadership strategies.

Course director Bo Walpole, MD, FACC, and course co-directors Cathleen Biga, MSN, RN, FACC, and Geoffrey Rose, MD, FACC, have designed CV Summit for members of all practices—private, integrated and academic—to discover innovative approaches to patient care and clinician experience in the areas of: managing rapid change, transforming cardiovascular care, optimizing the clinician experience, navigating health care economics and enhancing the academic agenda. Participants will learn to employ leadership strategies that foster collaboration, teamwork, diversity and inclusivity, along with best practices to sustain workforce well-being, key elements of a value-based practice environment and much more.

Participants will also be able to join Biga and select faculty for a pre-conference workshop on Wednesday, Feb. 16, 6:30-8:00 p.m. ET to discuss “Building Your Foundation for the Cardiovascular Summit.”

Live Sessions Include:

  • How to Fix Healthcare
  • Planning for the Inevitable: Workforce and Patient Access Challenges
  • Culture Change: Professionalism, Anti-Bullying, and Harassment – What Do You Do at Your Institution to Approach These Challenges?
  • Health Care Systems, Employed Cardiovascular Physicians, and Independent Practices: Challenges and Opportunities

Posters

The following abstracts are a selection of the posters being presented. All ACC Cardiovascular Summit abstracts are embargoed until Monday, Feb. 14, 2022, at 9 a.m. ET.

  • Improving Blood Pressure Management Through Blood Pressure Recheck Compliance
  • Reducing Patient Blood Pressure Using the Hypertension Bootcamp Approach with Remote Patient Monitoring
  • Enhanced External Counterpulsation Improves Outcomes in Patients with Long COVID
  • Association Between Erectile Dysfunction, Cardiovascular Risk Factors and Coronary Artery Disease: Role of Exercise Stress Testing and International Index of Erectile Function Questionnaire
  • Improving Emergency Medical Services First Medical Contact to Primary Coronary Intervention Time
SourceAmerican College of Cardiology

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

0
Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

0
Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

0
Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

0
The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

0
“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

About us

Medical Device News Magazine

Welcome to Medical Device News Magazine, a digital publication providing up to the minute medical device news and biotechnology news.

Need to know more?

Contact us

Navigation

Florida, New York
United States
Phone Number: 1.561.316.3330

Exit mobile version